Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection.

AIDS (London, England)

2000

https://researcherprofiles.org/profile/1422121

11089619

Bonhoeffer S, Rembiszewski M, Ortiz GM, Nixon DF